Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

The MHRA has revealed it's received more than 560 reports of acute pancreatitis in patients taking GLP-1 injections since ...

You've heard about the likes of Ozempic, Wegovy and Mounjaro, jabs which a growing number of people are taking in an attempt ...

The company is seeking regulatory approval of generic Ozempic by September from Canadian authorities, along with other emerging markets, Bloomberg News reported.

The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Lizzo is sharing some of the secrets to her transformational weight loss. The singer, 37, won't say how much weight she's ...

WEIGHT loss, warding off dementia, ‘curing’ diabetes and now… anti-ageing powers? Is there anything the so-called fat jabs can’t do? While a medicine that reverses the clock would be a ...

Discover budget-friendly foods that naturally curb appetite like Ozempic An expert shares the best fibre protein and healthy ...

Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...

Biocon Ltd. is set to seek regulatory approvals for generic versions of Novo Nordisk's Ozempic and Wegovy, targeting key ...